Pancreatic Cancer: Drugs

Department of Health written question – answered on 8th December 2014.

Alert me about debates like this

Photo of Rosie Cooper Rosie Cooper Labour, West Lancashire

To ask the Secretary of State for Health, what progress he has made on the decision-making process on whether the most effective medicines will continue to be made available to patients with pancreatic cancer on the NHS.

Photo of George Freeman George Freeman The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing advice to the National Health Service on the clinical and cost-effectiveness of health technologies. NICE has been asked to appraise a number of pancreatic cancer drugs and commissioners will continue to be legally required to fund treatments recommended by NICE technology appraisal guidance.

Decisions on the drugs made available through the Cancer Drugs Fund are a matter for NHS England’s Cancer Drugs Fund panel. The standard operating procedures for the Fund, which outline the decision-making process the panel follows is available at:

We are committed to maintaining the Cancer Drugs Fund until the end of March 2016. We will carefully consider with NHS England what arrangements should be put in place for the long term.

Does this answer the above question?

Yes0 people think so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.